Henry ScheinHSICEarnings & Financial Report
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners. For 14 consecutive years, the company has been named as one of the World's Most Ethical Companies by Ethisphere, most recently in 2025.
HSIC Q3 2025 Key Financial Metrics
营收
$3.3B
毛利润
$1.0B
营业利润
$164.0M
净利润
$101.0M
毛利率
30.7%
营业利润率
4.9%
净利率
3.0%
同比增长
5.2%
EPS
$0.84
资金流向
Henry Schein Q3 2025 Financial Summary
Henry Schein reported revenue of $3.3B for Q3 2025, with a net profit of $101.0M (3.0% margin). Cost of goods sold was $2.3B, operating expenses totaled $862.0M.
Key Financial Metrics
| Total Revenue | $3.3B |
|---|---|
| Net Profit | $101.0M |
| Gross Margin | 30.7% |
| Operating Margin | 4.9% |
| Report Period | Q3 2025 |
Henry Schein Annual Revenue by Year
Henry Schein annual revenue history includes year-by-year totals (for example, 2024 revenue was $12.7B).
| Year | Annual Revenue |
|---|---|
| 2024 | $12.7B |
| 2023 | $12.2B |
| 2022 | $12.6B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $3.02B | $3.17B | $3.14B | $3.17B | $3.19B | $3.17B | $3.24B | $3.34B |
| 同比增长 | -10.5% | N/A | 2.5% | 2.4% | N/A | -0.1% | 3.3% | 5.2% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $10.57B | $10.14B | $10.25B | $10.61B | $10.22B | $10.48B | $10.91B | $11.10B |
| 总负债 | $5.42B | $5.11B | $5.25B | $5.63B | $5.38B | $5.76B | $6.01B | $6.20B |
| 股东权益 | $3.65B | $3.60B | $3.51B | $3.50B | $3.39B | $3.31B | $3.44B | $3.36B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $-32.0M | $197.0M | $296.0M | $151.0M | $204.0M | $37.0M | $120.0M | $174.0M |
Other Health Care Companies
CAH
Cardinal Health
营收
$65.6B
净利润
$467.0M
COR
Cencora
营收
$85.9B
净利润
$559.6M
MCK
McKesson Corporation
营收
$106.2B
净利润
$1.2B
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BDX
Becton Dickinson
营收
$5.3B
净利润
$382.0M